REFERENCES
- Sibai B, Dekker G, Kupfermic M. Pre-eclampsia. Lancet 2005; 365: 785–799, [INFOTRIEVE], [CSA]
- Lachmeijer AM, Dekker GA, Pals G, Aarnoudse JG, ten Kate LP, Arngrimsson R. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 2002; 105: 94–113, [INFOTRIEVE], [CSA]
- Le Bouteiller P, Pizzato N, Solier C. HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol 2003; 59: 219–234, [INFOTRIEVE], [CSA], [CROSSREF]
- Le Bouteiller P, Blaschitz A. The functionality of HLA-G is emerging. Immunol Rev 1999; 167: 233–244, [INFOTRIEVE], [CSA], [CROSSREF]
- Goldman-Wohl DS, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S, Yagel S. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 2000; 6: 88–95, [INFOTRIEVE], [CSA], [CROSSREF]
- Matte C, Lacaille J, Zijenah L, Ward B, Roger M. HLA-G exhibits low level of polymorphism in indigenous East Africans. Hum Immunol 2002; 63: 495–501, [INFOTRIEVE], [CSA], [CROSSREF]
- Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, Varner MW. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001; 344: 867–872, [INFOTRIEVE], [CSA], [CROSSREF]
- Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LK, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ, [CSA]
- Wilton AN, Cooper DW, Brennecke SP, Bishop SM, Marshall P. Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/eclampsia and HLA DR beta. Lancet 1990; 336: 653–657, [INFOTRIEVE], [CSA], [CROSSREF]
- Lade JA, Moses EK, Guo G, Wilton AN, Grehan M, Cooper DW, Brennecke SP. The eNOS gene: a candidate for the preeclampsia susceptibility locus?. Hypertens Pregnancy 1999; 18: 81–93, [INFOTRIEVE], [CSA]
- Moses EK, Lade JA, Guo G, Wilton AN, Grehan M, Freed K, Borg A, Terwilliger JD, North R, Cooper DW, Brennecke SP. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am J Hum Genet 2000; 67: 1581–1585, [INFOTRIEVE], [CSA], [CROSSREF]
- Higgins JR, Kaiser T, Moses EK, North R, Brennecke SP. Prothrombin G20210A mutation: is it associated with pre-eclampsia?. Gynecol Obstet Invest 2000; 50: 254–257, [INFOTRIEVE], [CSA], [CROSSREF]
- Kaiser T, Brennecke SP, Moses EK. Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for pre-eclampsia/eclampsia in Australian women. Gynecol Obstet Invest 2000; 50: 100–102, [INFOTRIEVE], [CSA], [CROSSREF]
- Kaiser T, Grehan M, Brennecke SP, Moses EK. Association of the TNF2 Allele with Eclampsia. Gynecol Obstet Invest 2004; 57: 204–209, [INFOTRIEVE], [CSA], [CROSSREF]
- Fitzpatrick E, Goring H, Liu H, Borg A, Forrest S, Cooper DW, Brennecke SP, Moses EK. Fine mapping and SNP analysis of positional candidates at the pre-eclampsia susceptibility locus PREG1, on chromosome 2. Hum Biol 2004; 76: 849–862, [INFOTRIEVE], [CSA], [CROSSREF]
- Brown MA, Gallery EDM, Gatt SP, Leslie G, Robinson J. Management of hypertension in pregnancy: Executive summary. Med J Aust 1993; 158: 700–702, [CSA]
- Pazmany L, Mandelboim O, Vales-Gomez M, Davis DM, Reyburn HT, Strominger JL. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996; 274: 792–795, [INFOTRIEVE], [CSA], [CROSSREF]
- Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, Geraghty DE. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003; 171: 1376–1384, [INFOTRIEVE], [CSA]
- Ober C, Aldrich C, Rosinsky B, Robertson A, Walker MA, Willadsen S, Verp MS, Geraghty DE, Hunt JS. HLA-G1 protein expression is not essential for fetal survival. Placenta 1998; 19: 127–132, [INFOTRIEVE], [CSA], [CROSSREF]
- Menier C, Riteau B, Dausset J, Carosella ED, Rouas-Freiss N. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. Hum Immunol 2000; 61: 1118–1125, [INFOTRIEVE], [CSA], [CROSSREF]
- Hviid TV, Hylenius S, Lindhard A, Christiansen OB. Association between human leukocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome. Tissue Antigens 2004; 64: 66–69, [INFOTRIEVE], [CSA], [CROSSREF]
- Ober C, Aldrich CL, Chervoneva I, Billstrand C, Rahimov F, Gray HL, Hyslop T. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003; 72: 1425–1435, [INFOTRIEVE], [CSA], [CROSSREF]
- Hylenius S, Andersen AM, Melbye M, Hviid TV. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod 2004; 10: 237–246, [INFOTRIEVE], [CSA], [CROSSREF]
- Hviid TV. HLA-G genotype is associated with fetoplacental growth. Hum Immunol 2004; 65: 586–593, [INFOTRIEVE], [CSA], [CROSSREF]
- Yamashita T, Fujii T, Tokunaga K, Tadokoro K, Hamai Y, Miki A, Kozuma S, Juji T, Taketani Y. Analysis of human leukocyte antigen-G polymorphism including intron 4 in Japanese couples with habitual abortion. Am J Reprod Immunol 1999; 41: 159–163, [INFOTRIEVE], [CSA]
- Penzes M, Rajczy K, Gyodi E, Reti M, Feher E, Petranyi G. HLA-G gene polymorphism in the normal population and in recurrent spontaneous abortion in Hungary. Transplant Proc 1999; 31: 1832–1833, [INFOTRIEVE], [CSA], [CROSSREF]